Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ABSOLICON SOLAR COLLEC. B | ZY0 | Sep 19, 2024 | 0.63 | +0.64 |
AC Immune SA | IMR | Sep 19, 2024 | 3.25 | +0.46 |
Acacia Research Corporation | AZG2 | Sep 19, 2024 | 4.16 | -0.48 |
AcadeMedia | V8T | Sep 19, 2024 | 5.96 | +0.17 |
Acadia Healthcare Company, Inc. | 7RA | Sep 19, 2024 | 70.00 | +0.72 |
ACADIA Pharmaceuticals Inc. | DR6 | Sep 19, 2024 | 14.66 | +1.00 |
Acadia Realty Trust | WX1 | Sep 19, 2024 | 20.20 | 0.00 |
Acadian Timber Corp | 779 | Sep 19, 2024 | 11.30 | 0.00 |
Acanthe Developpement SA | ADX | Sep 19, 2024 | 0.32 | -0.31 |
Acarix | 7AC | Sep 19, 2024 | 0.02 | +3.86 |
Acast AB | 0PN | Sep 19, 2024 | 1.47 | -0.34 |
Acasti Pharma A | A1P0 | Sep 19, 2024 | 2.46 | +2.50 |
Accelerate Diagnostics | 1A80 | Sep 19, 2024 | 1.31 | +0.77 |
ACCELLERON IND. ADR/1 | ZH20 | Sep 19, 2024 | 44.60 | +2.29 |
Accent Resources NL | A2R | Sep 19, 2024 | 0.01 | 0.00 |
Accentis S.A. | D1Z | Sep 19, 2024 | 0.02 | -4.76 |
Accentro Real Estate AG | A4Y | Sep 19, 2024 | 0.47 | +43.03 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Sep 19, 2024 | 299.85 | -0.25 |
Accesso Technology Group Plc | LQG | Sep 19, 2024 | 5.95 | -0.83 |
Acciona SA | AJ3 | Sep 19, 2024 | 132.50 | +1.15 |
Acco Brands Corporation | A3B | Sep 19, 2024 | 4.80 | +1.27 |
Accolade, Inc. | 4NE1 | Sep 19, 2024 | 3.74 | -2.60 |
Acconeer | 2LU | Sep 19, 2024 | 0.62 | +2.15 |
Accor | ACR1 | Sep 19, 2024 | 7.65 | 0.00 |
Accor SA | ACR | Sep 19, 2024 | 39.15 | +1.32 |
Accsys Technologies | 1D8 | Sep 19, 2024 | 0.60 | -3.54 |
Accuray Incorporated | XEJ | Sep 19, 2024 | 1.70 | +1.19 |
Ace Hardware Indonesia TBK | 4AH1 | Sep 19, 2024 | 0.04 | 0.00 |
ACE LIBERTY+STONE LS -,25 | 8MW | Sep 19, 2024 | 0.56 | +6.73 |
ACEA SpA | DCA | Sep 19, 2024 | 17.17 | -0.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.